EPHB4: A Non-Coding RNA Molecule as A Potential Drug Target and Biomarker

Target Name: EPHB4

NCBI ID: G2050

EPHB4: A Non-Coding RNA Molecule as A Potential Drug Target and Biomarker

EPHB4 (Myk1) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and function have made it an attractive target for researchers to study and develop new treatments.

The EPHB4 molecule is a key regulator of the myeloid-derived growth factor (MDF) pathway, a critical signaling pathway that regulates the development and function of white blood cells. The MDF pathway is involved in the regulation of various cellular processes, including cell growth, differentiation, and inflammation. EPHB4 plays a crucial role in the regulation of MDF signaling by binding to and stabilizing the MDF receptor, which is a protein that plays a critical role in the regulation of cellular processes such as cell growth, differentiation, and survival.

EPHB4 has been shown to be involved in the regulation of various cellular processes, including cell growth, differentiation, and apoptosis. It has been shown to promote the growth and proliferation of cancer cells, and it has also been shown to contribute to the development of neurodegenerative diseases. EPHB4 has been shown to play a role in the regulation of inflammation, and it has been shown to be involved in the development of autoimmune disorders.

Due to its involvement in the MDF pathway and its ability to regulate cellular processes, EPHB4 has been identified as a potential drug target for a variety of diseases. One of the main advantages of targeting EPHB4 is its small size and its non-coding nature, which makes it relatively easy to manipulate and study. Additionally, EPHB4 is highly expressed in various tissues and cells, which makes it a potential biomarker for a variety of diseases.

In cancer, EPHB4 has been shown to promote the growth and proliferation of various types of cancer cells, including breast, lung, and ovarian cancer. EPHB4 has also been shown to contribute to the development of resistance to chemotherapy in cancer cells. Targeting EPHB4 with drugs that can inhibit its activity may be an effective way to treat various types of cancer.

In neurodegenerative diseases, EPHB4 has been shown to contribute to the development and progression of conditions such as Alzheimer's disease and Parkinson's disease. EPHB4 has been shown to regulate the activity of the neurotransmitter dopamine, which plays a critical role in the regulation of mood, appetite, and movement. In addition, EPHB4 has been shown to regulate the activity of the protein tau, which is involved in the development of neurodegenerative diseases.

In autoimmune disorders, EPHB4 has been shown to contribute to the development and progression of conditions such as rheumatoid arthritis and multiple sclerosis. EPHB4 has been shown to regulate the activity of the immune cell T-cell, which plays a critical role in the regulation of immune responses.

In conclusion, EPHB4 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for a variety of diseases. Its unique structure and function have made it an attractive target for researchers to study and develop new treatments. Further research is needed to fully understand the role of EPHB4 in the regulation of cellular processes and its potential as a drug target and biomarker.

Protein Name: EPH Receptor B4

Functions: Receptor tyrosine kinase which binds promiscuously transmembrane ephrin-B family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Together with its cognate ligand/functional ligand EFNB2 it is involved in the regulation of cell adhesion and migration, and plays a central role in heart morphogenesis, angiogenesis and blood vessel remodeling and permeability. EPHB4-mediated forward signaling controls cellular repulsion and segregation from EFNB2-expressing cells

More Common Targets